VEGFA and neoplasm: On the other hand, in breast cancer, the combination of Minocycline and Celecoxib inhibits tumor cell growth, decreases the micro-vessel density, and lowers the expression of vascular endothelial growth factor (VEGF) and matrix metalloproteinase [64].